Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 149
- News
DHSC Confirms Further 6-Month Extension For Import Of Life Saving Childrens’ Epilepsy Drugs
THE Department of Health & Social Care (DHSC) has announced that emergency measures to ensure supplies of childrens’ epilepsy cannabis medication remain accessible in the UK will be extended for another three months.
- CBD Market
Charlotte’s Web Signs Exclusive UK Distribution Agreement with Savage Cabbage
CHARLOTTE’S Web Holdings, Inc., (“Charlotte’s Web” or the “Company”), the market leader in cannabidiol (“CBD”) hemp extract wellness products, has signed an exclusive product distribution agreement in the United Kingdom with Savage Cabbage Ltd., one of the oldest and most trusted CBD companies in the UK, serving an active and loyal customer base of wellness seekers.
- Medical
Dr Reddy’s Entrance Into Cannabis Industry Likely To Bring More Indian Big-Pharma Investment
INDIA’S fourth largest pharmaceutical company Dr Reddy’s Labs (DRL), became the latest big-pharma company to break ground in the European cannabis industry last month.
- Markets & Stocks
EU Cannabis Stocks Review: Cellular Goods Stock Jumps 50% After Marketing Campaign Launch, SEED Innovations Enjoys Recovery, More from DeepVerge & Akanda
FOLLOWING a difficult few weeks for European cannabis stocks, last week saw many enjoy a recovery amid a flurry of positive announcements from both the industry and individual companies.
- News
UK Cannabis Firm Akanda’s US Listing Sees Value Skyrocket As It Unveils Plans To ‘Put Capital To Work’
AKANDA Corp has become the latest British cannabis company to go public after it launched on the NASDAQ Stock Exchange this week, seeing its stock soar some 350% above its listing price.
- Pharmaceutical
OCT Co-Founder Publishes Scathing Letter Accusing Directors of ‘Serious Governance & Management’ Failings Ahead of GM Vote to Oust Board
GAVIN Sathianathan, a founder member of Oxford Cannabinoid Technologies (OCT), published a bombshell letter to fellow investors last week laying bare the numerous reasons behind his call for the company’s board to be replaced.
- Pharmaceutical
EU Cannabis Stocks Review: OCT Board Accused of Serious Governance Issues by Co-Founder, Panaxia’s Debt Pile Hits Stock & More from Love Hemp
AS European Cannabis stocks continue their battle against external market forces, it has been internal battles which made the headlines this week.
- CBD Market
CBD By British Cannabis UK TV Campaign Debuts Nationwide
BRITISH Cannabis™ (registered as CBD Health Foods Ltd) has launched a media campaign for its premium flagship range CBD by British Cannabis, as part of a half a million pound awareness and consumer recruitment campaign for 2022/23.
- News
Love Hemp Stakeholder Demands Ousting Of Chairman And End to Marketing Spend
A SIGNIFICANT investor in Love Hemp has demanded that the company’s Chairman be removed, all director and board member’s salaries be slashed by 75% and that a financial review into its spending be launched.
- Pharmaceutical
One Year After The First Cannabis Stocks Joined The LSE, Could We See A Fresh Run Of Cannabis IPOs This Year?
FEBRUARY 2022 marked the one-year anniversary of MGC Pharmaceuticals IPO on the London Stock Exchange, which saw cannabis stocks traded on the platform for the first time in its 320-year history.
- Markets & Stocks
EU Cannabis Stocks Review: How Ukraine Crisis Is Impacting Cannabis Stocks, Chill Brands’ Revenue Could Be $1m Less & More From Tilray and MGC Pharma
LAST week began with a number of European cannabis stocks levelling out following dramatic declines days earlier in reaction to Russia’s invasion of Ukraine.
- News
Infrastructure Giant Peel Wants To Break Into Cannabis Industry With Multi-Million Pound Facility
THE project will be Peel’s inaugural foray into the cannabis industry, pointing to a wider shift in sentiment from larger corporations, an increasing number of which now recognise the financial opportunities it has to offer.
